Fujimoto Y, Wada K, Kaneko M, Fujita T
Department of Hygienic Chemistry, Osaka University of Pharmaceutical Sciences, Japan.
Br J Pharmacol. 1987 Nov;92(3):479-81. doi: 10.1111/j.1476-5381.1987.tb11346.x.
The effect of YS980, an angiotensin-converting enzyme inhibitor, on the generation of medullary prostaglandins E2 and F2 alpha was examined. At concentrations of 0.2 mM and below, YS980 enhanced prostaglandin F2 alpha synthesis at the expense of prostaglandin E2. At concentrations of 0.4 mM or more, YS980 inhibited synthesis of both prostaglandins E2 and F2 alpha markedly. These results suggest that YS980 has the potential to modulate prostaglandins E2 and F2 alpha synthesis by the kidney and that this effect may represent some pharmacological action of the drug.
研究了血管紧张素转换酶抑制剂YS980对髓质前列腺素E2和F2α生成的影响。在浓度为0.2 mM及以下时,YS980以牺牲前列腺素E2为代价增强了前列腺素F2α的合成。在浓度为0.4 mM或更高时,YS980显著抑制前列腺素E2和F2α的合成。这些结果表明,YS980有可能调节肾脏中前列腺素E2和F2α的合成,并且这种作用可能代表了该药物的某些药理作用。